DA
ALXN
DSC Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-69,000
| Closed | -$10.8M | – | 85 |
|
|
2020
Q4 | $10.8M | Hold |
69,000
| – | – | 8.91% | 4 |
|
|
2020
Q3 | $7.9M | Buy |
69,000
+26,500
| +62% | +$3.03M | 5.28% | 4 |
|
|
2020
Q2 | $4.77M | Sell |
42,500
-2,500
| -6% | -$281K | 5.23% | 7 |
|
|
2020
Q1 | $4.04M | Sell |
45,000
-23,500
| -34% | -$2.11M | 3.95% | 7 |
|
|
2019
Q4 | $7.41M | Buy |
68,500
+16,000
| +30% | +$1.73M | 3.55% | 12 |
|
|
2019
Q3 | $5.14M | Buy |
52,500
+7,500
| +17% | +$735K | 1.02% | 13 |
|
|
2019
Q2 | $5.89M | Hold |
45,000
| – | – | 1.04% | 14 |
|
|
2019
Q1 | $6.08M | Sell |
45,000
-10,000
| -18% | -$1.35M | 1.12% | 13 |
|
|
2018
Q4 | $5.36M | Buy |
+55,000
| New | +$5.36M | 0.65% | 14 |
|